Argosy recapitalizes Hudson Robotics and merges it with Art Robbins Instruments
Argosy Healthcare Partners completed a recapitalization and merger that combined Hudson Robotics with Art Robbins Instruments.
Evidence notes
- Argosy Healthcare Partners completed the control transaction and backed the combined life-sciences tools company.
- The merger joined Hudson robotic liquid handling and microplate automation with Art Robbins protein-crystallization and liquid-handling instruments.
- Andrew Witschi became chief executive of the combined company, with plans to reinvest in commercialization, product development and SoftLinx software.